SCHEMBL10504227

SCHEMBL10504227

CCON=C(C(=O)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(CCl)CS[C@@H]12)c1nsc(N)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.55
▸ PTGS1 P23219 2/20 0.44
▸ ABCB11 O95342 1/20 0.44
▸ PDE4D Q08499 1/20 0.44
▸ NR1I2 O75469 5/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ ABCC4 O15439 1/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ MAPT P10636 4/20 0.41
▸ PPARG P37231 2/20 0.41
▸ ALB P02768 1/20 0.41
▸ SLC22A6 Q4U2R8 1/20 0.41
▸ SLC22A8 Q8TCC7 1/20 0.41
▸ SLC22A11 Q9NSA0 1/20 0.41
▸ KMT2A Q03164 3/20 0.41
▸ TDP1 Q9NUW8 5/20 0.40
▸ ALDH1A1 P00352 5/20 0.40
▸ HSD17B10 Q99714 4/20 0.40
▸ TSHR P16473 2/20 0.40
▸ LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10532770 1.00 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL10504223 1.00 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9012930 0.94 KCNH2 (0.48) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9012935 0.94 KCNH2 (0.48) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9624027 0.93 KCNH2 (0.48) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9624032 0.93 KCNH2 (0.48) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL4337805 0.93 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9624448 0.93 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL9624450 0.93 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2
SCHEMBL4337797 0.93 KCNH2 (0.55) KCNH2PTGS1ABCB11PDE4DNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0103264-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-12-20 — — EP disclosed
EP-0074653-B1 NEW CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATE PRODUCTS FOR THEIR PREPARATION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-04-26 — — EP disclosed
EP-0062321-B1 NEW CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR STARTING COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-03-01 — — EP disclosed
EP-0231475-A1 Process for preparing intermediate products and their use for preparing cephem compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-08-12 — — EP disclosed
US-4639448-A 7-amino-3-[substituted vinyl]-3-cephem-4-carboxylates having antimicrobial activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-01-27 — — US disclosed
US-4546101-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-10-08 — — US disclosed
US-4521413-A Cephem compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-06-04 — — US disclosed
US-4463000-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-31 — — US disclosed
US-4457928-A BACTERICIDAL CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-07-03 — — US disclosed
EP-0103264-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-03-21 — — EP disclosed
US-4431642-A CEPHALOSPORINS; BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-02-14 — — US disclosed
EP-0074653-A2 New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and intermediate products for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-03-23 — — EP disclosed
EP-0062321-A2 New cephem compounds, processes for their preparation, pharmaceutical compositions containing them and their starting compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1982-10-13 — — EP disclosed
EP-0042154-A1 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-23 — — EP disclosed
Send feedback